Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival  Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti,

Published byAlbert Richardson Modified over 5 years ago

Similar presentations

Presentation on theme: "Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival  Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti,"— Presentation transcript:

1 Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival 
Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti, MD, Gabriele Pelissero, MD, Marco Ranucci, MD  The Annals of Thoracic Surgery  Volume 92, Issue 2, Pages (August 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival rate (including hospital mortality) after tracheostomy in cardiac surgical patients. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Survival rate for patients alive at discharge from the hospital after cardiac operations. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival rate for patients alive at discharge, according to the clinical condition (respiratory, solid line; neurologic, dashed line; cardiac, dotted line) leading to ventilator dependency and tracheostomy. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival  Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Impact of Moderate Ischemic Mitral Regurgitation After Isolated Coronary Artery Bypass Grafting  Khalil Fattouch, MD, PhD, Roberta Sampognaro, MD, Giuseppe.

Impact of Moderate Ischemic Mitral Regurgitation After Isolated Coronary Artery Bypass Grafting  Khalil Fattouch, MD, PhD, Roberta Sampognaro, MD, Giuseppe.
Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,

Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery  Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Mortality and Morbidity After Total Aortic Arch Replacement

Mortality and Morbidity After Total Aortic Arch Replacement
Clinical Outcomes in Patients With Prolonged Intensive Care Unit Length of Stay After Cardiac Surgical Procedures  Ansar Hassan, MD, PhD, Curtis Anderson,

Clinical Outcomes in Patients With Prolonged Intensive Care Unit Length of Stay After Cardiac Surgical Procedures  Ansar Hassan, MD, PhD, Curtis Anderson,
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Liver and Cardiac Function in the Long Term After Fontan Operation

Liver and Cardiac Function in the Long Term After Fontan Operation
Niv Ad, MD, Linda Henry, PhD, Sharon Hunt, MBA, Sari D. Holmes, PhD 

Niv Ad, MD, Linda Henry, PhD, Sharon Hunt, MBA, Sari D. Holmes, PhD 
Surgical Excision of Cardiac Myxomas: Twenty Years Experience at a Single Institution  Andrea Garatti, MD, Giovanni Nano, MD, Alberto Canziani, MD, Piervincenzo.

Surgical Excision of Cardiac Myxomas: Twenty Years Experience at a Single Institution  Andrea Garatti, MD, Giovanni Nano, MD, Alberto Canziani, MD, Piervincenzo.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Tetralogy of Fallot: surgical management individualized to the patient

Tetralogy of Fallot: surgical management individualized to the patient
Surgical Ventricular Restoration: Is There Any Difference in Outcome Between Anterior and Posterior Remodeling?  Andrea Garatti, MD, Serenella Castelvecchio,

Surgical Ventricular Restoration: Is There Any Difference in Outcome Between Anterior and Posterior Remodeling?  Andrea Garatti, MD, Serenella Castelvecchio,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V

Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

Similar presentations

Ads by Google